Oligodendrogenesis from neural stem cells: Perspectives for remyelinating strategies

International Journal of Developmental Neuroscience

Volumn 31, Issue 7, 2013, Pages 692-700

  Grade, Sofia ^a   Bernardino, Liliana ^a,c   Malva, João O ^a,b  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF BEIRA INTERIOR   (Portugal)

Author keywords

Cell therapy; CNS repair; Multiple sclerosis; Neural stem cells; Oligodendrocytes; Remyelination

Indexed keywords

LIOTHYRONINE;

ALLERGIC ENCEPHALOMYELITIS; BRAIN DAMAGE; CELL SURVIVAL; CONVALESCENCE; COST CONTROL; GENETIC ENGINEERING; HUMAN; MULTIPLE SCLEROSIS; NERVE CELL DIFFERENTIATION; NERVE FIBER REGENERATION; NEURAL STEM CELL; NEURAL STEM CELL TRANSPLANTATION; NONHUMAN; OLIGODENDROCYTE PRECURSOR CELL; PATIENT SAFETY; PRIORITY JOURNAL; REGENERATIVE MEDICINE; REMYELINIZATION; REVIEW; STEM CELL MOBILIZATION; STEM CELL RESEARCH; TREATMENT OUTCOME;

2′,3′-CYCLIC NUCLEOTIDE-3′-PHOSPHODIESTERASE; CELL THERAPY; CENTRAL NERVOUS SYSTEM; CNP; CNS; CNS REPAIR; CPZ; CUPRIZONE; DAYS IN VITRO; DENTATE GYRUS; DG; DIV; EAE; EGFP; EMBRYONIC NEURAL STEM CELLS; ENHANCED-GREEN FLUORESCENT PROTEIN; ENSCS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; INDUCIBLE PLURIPOTENT STEM CELLS; IPSCS; MAG; MBP; MESENCHYMAL STEM CELLS; MS; MSCS; MULTIPLE SCLEROSIS; MYELIN BASIC PROTEIN; MYELIN-ASSOCIATED GLYCOPROTEIN; NERVE GROWTH FACTOR; NEURAL PRECURSOR CELLS; NEURAL STEM CELLS; NGF; NPCS; NSCS; OLIGODENDROCYTE PRECURSOR CELLS; OLIGODENDROCYTES; OPCS; PDGFRΑ; PERIPHERAL NERVOUS SYSTEM; PLATELET-DERIVED GROWTH FACTOR RECEPTOR ALPHA; PLP; PNS; PROTEOLIPID PROTEIN; REMYELINATION; SUBVENTRICULAR ZONE; SVZ; T3; T3 RECEPTORS; TRIIODOTHYRONINE; TRS;

ANIMALS; CELL DIFFERENTIATION; HUMANS; NEURAL STEM CELLS; OLIGODENDROGLIA;

EID: 84887612588     PISSN: 07365748     EISSN: 1873474X     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2013.01.004     Document Type: Review

References (92)

1. Agasse F., Bernardino L., Silva B., Ferreira R., Grade S., Malva J.O. Response to histamine allows the functional identification of neuronal progenitors, neurons, astrocytes, and immature cells in subventricular zone cell cultures. Rejuvenation Research 2008, 11:187-200.
2. Akiyama Y., Honmou O., Kato T., Uede T., Hashi K., Kocsis J.D. Transplantation of clonal neural precursor cells derived from adult human brain establishes functional peripheral myelin in the rat spinal cord. Experimental Neurology 2001, 167:27-39.
3. Albrecht P.J., Murtie J.C., Ness J.K., Redwine J.M., Enterline J.R., Armstrong R.C., Levison S.W. Astrocytes produce CNTF during the remyelination phase of viral-induced spinal cord demyelination to stimulate FGF-2 production. Neurobiology of Disease 2003, 13:89-101.
4. Althaus H.H. Remyelination in multiple sclerosis: a new role for neurotrophins?. Progress in Brain Research 2004, 146:415-432.
5. Armstrong R.C., Le T.Q., Flint N.C., Vana A.C., Zhou Y.X. Endogenous cell repair of chronic demyelination. Journal of Neuropathology and Experimental Neurology 2006, 65:245-256.
6. Azim K., Raineteau O., Butt A.M. Intraventricular injection of FGF-2 promotes generation of oligodendrocyte-lineage cells in the postnatal and adult forebrain. Glia 2012, 60:1977-1990.
7. Baas D., Legrand C., Samarut J., Flamant F. Persistence of oligodendrocyte precursor cells and altered myelination in optic nerve associated to retina degeneration in mice devoid of all thyroid hormone receptors. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:2907-2911.
8. Barnett M.H., Prineas J.W. Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Annals of Neurology 2004, 55:458-468.
9. Barres B.A., Lazar M.A., Raff M.C. A novel role for thyroid hormone, glucocorticoids and retinoic acid in timing oligodendrocyte development. Development 1994, 120:1097-1108.
10. Billon N., Jolicoeur C., Tokumoto Y., Vennstrom B., Raff M. Normal timing of oligodendrocyte development depends on thyroid hormone receptor alpha 1 (TRalpha1). EMBO Journal 2002, 21:6452-6460.
11. Bin J.M., Leong S.Y., Bull S.J., Antel J.P., Kennedy T.E. Oligodendrocyte precursor cell transplantation into organotypic cerebellar shiverer slices: a model to study myelination and myelin maintenance. PLoS One 2012, 7:e41237.
12. Blakemore W.F., Crang A.J. The use of cultured autologous Schwann cells to remyelinate areas of persistent demyelination in the central nervous system. Journal of the Neurological Sciences 1985, 70:207-223.
13. Blakemore W.F., Crang A.J. Extensive oligodendrocyte remyelination following injection of cultured central nervous system cells into demyelinating lesions in adult central nervous system. Developmental Neuroscience 1988, 10:1-11.
14. Butt A.M., Dinsdale J. Fibroblast growth factor 2 induces loss of adult oligodendrocytes and myelin in vivo. Experimental Neurology 2005, 192:125-133.
15. Calver A.R., Hall A.C., Yu W.P., Walsh F.S., Heath J.K., Betsholtz C., Richardson WD Oligodendrocyte population dynamics and the role of PDGF in vivo. Neuron 1998, 20:869-882.
16. Calza L., Giardino L., Aloe L. Thyroid hormone regulates NGF content and p75LNGFR expression in the basal forebrain of adult rats. Experimental Neurology 1997, 143:196-206.
17. Calza L., Fernandez M., Giuliani A., Aloe L., Giardino L Thyroid hormone activates oligodendrocyte precursors and increases a myelin-forming protein and NGF content in the spinal cord during experimental allergic encephalomyelitis. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:3258-3263.
18. Cammer W. The neurotoxicant, cuprizone, retards the differentiation of oligodendrocytes in vitro. Journal of the Neurological Sciences 1999, 168:116-120.
19. Cayre M., Bancila M., Virard I., Borges A., Durbec P. Migrating and myelinating potential of subventricular zone neural progenitor cells in white matter tracts of the adult rodent brain. Molecular and Cellular Neurosciences 2006, 31:748-758.
20. Chang A., Tourtellotte W.W., Rudick R., Trapp B.D. Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. New England Journal of Medicine 2002, 346:165-173.
21. Chari D.M., Blakemore W.F. Efficient recolonisation of progenitor-depleted areas of the CNS by adult oligodendrocyte progenitor cells. Glia 2002, 37:307-313.
22. Coman I., Barbin G., Charles P., Zalc B., Lubetzki C. Axonal signals in central nervous system myelination, demyelination and remyelination. Journal of the Neurological Sciences 2005, 233:67-71.
23. Crang A.J., Blakemore W.F. The effect of the number of oligodendrocytes transplanted into X-irradiated, glial-free lesions on the extent of oligodendrocyte remyelination. Neuroscience Letters 1989, 103:269-274.
24. Dussault J.H., Ruel J. Thyroid hormones and brain development. Annual Review of Physiology 1987, 49:321-334.
25. Fernandez M., Giuliani A., Pirondi S., D'Intino G., Giardino L., Aloe L., Levi-Montalcini R., Calza L. Thyroid hormone administration enhances remyelination in chronic demyelinating inflammatory disease. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:16363-16368.
26. Flachenecker P., Stuke K. National MS registries. Journal of Neurology 2008, 255(Suppl. 6):102-108.
27. Franco P.G., Silvestroff L., Soto E.F., Pasquini J.M. Thyroid hormones promote differentiation of oligodendrocyte progenitor cells and improve remyelination after cuprizone-induced demyelination. Experimental Neurology 2008, 212:458-467.
28. Franklin R.J., Blakemore W.F. To what extent is oligodendrocyte progenitor migration a limiting factor in the remyelination of multiple sclerosis lesions?. Multiple Sclerosis 1997, 3:84-87.
29. Franklin R.J., Ffrench-Constant C. Remyelination in the CNS: from biology to therapy. Nature Reviews: Neuroscience 2008, 9:839-855.
30. Franklin R.J., Bayley S.A., Blakemore W.F. Transplanted CG4 cells (an oligodendrocyte progenitor cell line) survive, migrate, and contribute to repair of areas of demyelination in X-irradiated and damaged spinal cord but not in normal spinal cord. Experimental Neurology 1996, 137:263-276.
31. Fritsche E., Cline J.E., Nguyen N.H., Scanlan T.S., Abel J. Polychlorinated biphenyls disturb differentiation of normal human neural progenitor cells: clue for involvement of thyroid hormone receptors. Environmental Health Perspectives 2005, 113:871-876.
32. Geurts J.J., Bo L., Roosendaal S.D., Hazes T., Daniels R., Barkhof F., Witter M.P., Huitinga I., van der Valk P. Extensive hippocampal demyelination in multiple sclerosis. Journal of Neuropathology and Experimental Neurology 2007, 66:819-827.
33. Grade S., Agasse F., Bernardino L., Malva J.O. Functional identification of neural stem cell-derived oligodendrocytes. Methods in Molecular Biology 2012, 879:165-178.
34. Grade S., Agasse F., Bernardino L., Silva C.G., Cortes L., Malva J.O. Functional identification of neural stem cell-derived oligodendrocytes by means of calcium transients elicited by thrombin. Rejuvenation Research 2010, 13:27-37.
35. Groves A.K., Barnett S.C., Franklin R.J., Crang A.J., Mayer M., Blakemore W.F., Noble M. Repair of demyelinated lesions by transplantation of purified O-2A progenitor cells. Nature 1993, 362:453-455.
36. Haber M., Vautrin S., Fry E.J., Murai K.K. Subtype-specific oligodendrocyte dynamics in organotypic culture. Glia 2009, 57:1000-1013.
37. Han D.W., Tapia N., Hermann A., Hemmer K., Hoing S., Arauzo-Bravo M.J., Zaehres H., Wu G., Frank S., Moritz S., Greber B., Yang J.H., Lee H.T., Schwamborn J.C., Storch A., Scholer H.R. Direct reprogramming of fibroblasts into neural stem cells by defined factors. Cell Stem Cell 2012, 10:465-472.
38. Hiremath M.M., Saito Y., Knapp G.W., Ting J.P., Suzuki K., Matsushima G.K. Microglial/macrophage accumulation during cuprizone-induced demyelination in C57BL/6 mice. Journal of Neuroimmunology 1998, 92:38-49.
39. Hoffmann K., Lindner M., Groticke I., Stangel M., Loscher W. Epileptic seizures and hippocampal damage after cuprizone-induced demyelination in C57BL/6 mice. Experimental Neurology 2008, 210:308-321.
40. Ioannidou K., Anderson K.I., Strachan D., Edgar J.M., Barnett S.C. Time-lapse imaging of the dynamics of CNS glial-axonal interactions in vitro and ex vivo. PLoS ONE 2012, 7:e30775.
41. Jackson E.L., Garcia-Verdugo J.M., Gil-Perotin S., Roy M., Quinones-Hinojosa A., VandenBerg S., Alvarez-Buylla A. PDGFR alpha-positive B cells are neural stem cells in the adult SVZ that form glioma-like growths in response to increased PDGF signaling. Neuron 2006, 51:187-199.
42. Jeannin E., Robyr D., Desvergne B. Transcriptional regulatory patterns of the myelin basic protein and malic enzyme genes by the thyroid hormone receptors alpha1 and beta1. Journal of Biological Chemistry 1998, 273:24239-24248.
43. Jiang Y., Boije M., Westermark B., Uhrbom L. PDGF-B can sustain self-renewal and tumorigenicity of experimental glioma-derived cancer-initiating cells by preventing oligodendrocyte differentiation. Neoplasia 2011, 13:492-503.
44. Johe K.K., Hazel T.G., Muller T., Dugich-Djordjevic M.M., McKay R.D. Single factors direct the differentiation of stem cells from the fetal and adult central nervous system. Genes and Development 1996, 10:3129-3140.
45. Kang S.M., Cho M.S., Seo H., Yoon C.J., Oh S.K., Choi Y.M., Kim D.W. Efficient induction of oligodendrocytes from human embryonic stem cells. Stem Cells 2007, 25:419-424.
46. Keirstead H.S., Ben-Hur T., Rogister B., O'Leary M.T., Dubois-Dalcq M., Blakemore W.F. Polysialylated neural cell adhesion molecule-positive CNS precursors generate both oligodendrocytes and Schwann cells to remyelinate the CNS after transplantation. Journal of Neuroscience 1999, 19:7529-7536.
47. Konig S., Moura Neto V. Thyroid hormone actions on neural cells. Cellular and Molecular Neurobiology 2002, 22:517-544.
48. Koutsoudaki P.N., Skripuletz T., Gudi V., Moharregh-Khiabani D., Hildebrandt H., Trebst C., Stangel M. Demyelination of the hippocampus is prominent in the cuprizone model. Neuroscience Letters 2009, 451:83-88.
49. Lachapelle F., Gumpel M., Baulac M., Jacque C., Duc P., Baumann N. Transplantation of CNS fragments into the brain of shiverer mutant mice: extensive myelination by implanted oligodendrocytes. I. Immunohistochemical studies. Developmental Neuroscience 1983, 6:325-334.
50. Lavdas A.A., Papastefanaki F., Thomaidou D., Matsas R. Schwann cell transplantation for CNS repair. Current Medicinal Chemistry 2008, 15:151-160.
51. Laywell E.D., Kukekov V.G., Steindler D.A. Multipotent neurospheres can be derived from forebrain subependymal zone and spinal cord of adult mice after protracted postmortem intervals. Experimental Neurology 1999, 156:430-433.
52. Legrand J. Thyroid hormone effects on growth and development. Thyroid Hormone Metabolism 1986, 503-534. M Dekker, Inc., New York. G. Hennemann (Ed.).
53. Levison S.W., Goldman J.E. Both oligodendrocytes and astrocytes develop from progenitors in the subventricular zone of postnatal rat forebrain. Neuron 1993, 10:201-212.
54. Lucchinetti C., Bruck W., Parisi J., Scheithauer B., Rodriguez M., Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Annals of Neurology 2000, 47:707-717.
55. Martino G., Pluchino S. The therapeutic potential of neural stem cells. Nature Reviews: Neuroscience 2006, 7:395-406.
56. Mason J.L., Toews A., Hostettler J.D., Morell P., Suzuki K., Goldman J.E., Matsushima G.K. Oligodendrocytes and progenitors become progressively depleted within chronically demyelinated lesions. American Journal of Pathology 2004, 164:1673-1682.
57. Matsushima G.K., Morell P. The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathology 2001, 11:107-116.
58. Menn B., Garcia-Verdugo J.M., Yaschine C., Gonzalez-Perez O., Rowitch D., Alvarez-Buylla A. Origin of oligodendrocytes in the subventricular zone of the adult brain. Journal of Neuroscience 2006, 26:7907-7918.
59. Murray K., Dubois-Dalcq M. Emergence of oligodendrocytes from human neural spheres. Journal of Neuroscience Research 1997, 50:146-156.
60. Nait-Oumesmar B., Decker L., Lachapelle F., Avellana-Adalid V., Bachelin C., Van Evercooren A.B. Progenitor cells of the adult mouse subventricular zone proliferate, migrate and differentiate into oligodendrocytes after demyelination. European Journal of Neuroscience 1999, 11:4357-4366.
61. Nait-Oumesmar B., Picard-Riera N., Kerninon C., Decker L., Seilhean D., Hoglinger G.U., Hirsch E.C., Reynolds R., Baron-Van Evercooren A. Activation of the subventricular zone in multiple sclerosis: evidence for early glial progenitors. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:4694-4699.
62. Norkute A., Hieble A., Braun A., Johann S., Clarner T., Baumgartner W., Beyer C., Kipp M. Cuprizone treatment induces demyelination and astrocytosis in the mouse hippocampus. Journal of Neuroscience Research 2009, 87:1343-1355.
63. Penderis J., Shields S.A., Franklin R.J. Impaired remyelination and depletion of oligodendrocyte progenitors does not occur following repeated episodes of focal demyelination in the rat central nervous system. Brain 2003, 126:1382-1391.
64. Picard-Riera N., Decker L., Delarasse C., Goude K., Nait-Oumesmar B., Liblau R., Pham-Dinh D., Evercooren A.B. Experimental autoimmune encephalomyelitis mobilizes neural progenitors from the subventricular zone to undergo oligodendrogenesis in adult mice. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:13211-13216.
65. Pluchino S., Zanotti L., Rossi B., Brambilla E., Ottoboni L., Salani G., Martinello M., Cattalini A., Bergami A., Furlan R., Comi G., Constantin G., Martino G. Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism. Nature 2005, 436:266-271.
66. Pluchino S., Quattrini A., Brambilla E., Gritti A., Salani G., Dina G., Galli R., Del Carro U., Amadio S., Bergami A., Furlan R., Comi G., Vescovi A.L., Martino G. Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. Nature 2003, 422:688-694.
67. Puymirat J. Thyroid receptors in the rat brain. Progress in Neurobiology 1992, 39:281-294.
68. Rivera F.J., Siebzehnrubl F.A., Kandasamy M., Couillard-Despres S., Caioni M., Poehler A.M., Berninger B., Sandner B., Bogdahn U., Goetz M., Bluemcke I., Weidner N., Aigner L. Mesenchymal stem cells promote oligodendroglial differentiation in hippocampal slice cultures. Cellular Physiology and Biochemistry 2009, 24:317-324.
69. Rogister B., Ben-Hur T., Dubois-Dalcq M. From neural stem cells to myelinating oligodendrocytes. Molecular and Cellular Neurosciences 1999, 14:287-300.
70. Shen S., Sandoval J., Swiss V.A., Li J., Dupree J., Franklin R.J., Casaccia-Bonnefil P. Age-dependent epigenetic control of differentiation inhibitors is critical for remyelination efficiency. Nature Neuroscience 2008, 11:1024-1034.
71. Sim F.J., Zhao C., Penderis J., Franklin R.J. The age-related decrease in CNS remyelination efficiency is attributable to an impairment of both oligodendrocyte progenitor recruitment and differentiation. Journal of Neuroscience 2002, 22:2451-2459.
72. Skripuletz T., Lindner M., Kotsiari A., Garde N., Fokuhl J., Linsmeier F., Trebst C., Stangel M. Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent. American Journal of Pathology 2008, 172:1053-1061.
73. Smith K.J., Blakemore W.F., McDonald W.I. Central remyelination restores secure conduction. Nature 1979, 280:395-396.
74. Smith K.J., Blakemore W.F., McDonald W.I. The restoration of conduction by central remyelination. Brain 1981, 104:383-404.
75. Smith P.M., Blakemore W.F. Porcine neural progenitors require commitment to the oligodendrocyte lineage prior to transplantation in order to achieve significant remyelination of demyelinated lesions in the adult CNS. European Journal of Neuroscience 2000, 12:2414-2424.
76. Strait K.A., Carlson D.J., Schwartz H.L., Oppenheimer J.H. Transient stimulation of myelin basic protein gene expression in differentiating cultured oligodendrocytes: a model for 3,5,3'-triiodothyronine-induced brain development. Endocrinology 1997, 138:635-641.
77. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
78. Taveggia C., Feltri M.L., Wrabetz L. Signals to promote myelin formation and repair. Nature Reviews: Neurology 2010, 6:276-287.
79. Tokumoto Y.M., Durand B., Raff M.C. An analysis of the early events when oligodendrocyte precursor cells are triggered to differentiate by thyroid hormone, retinoic acid, or PDGF withdrawal. Developmental Biology 1999, 213:327-339.
80. Tosic M., Torch S., Comte V., Dolivo M., Honegger P., Matthieu J.M. Triiodothyronine has diverse and multiple stimulating effects on expression of the major myelin protein genes. Journal of Neurochemistry 1992, 59:1770-1777.
81. Utzschneider D.A., Archer D.R., Kocsis J.D., Waxman S.G., Duncan I.D. Transplantation of glial cells enhances action potential conduction of amyelinated spinal cord axons in the myelin-deficient rat. Proceedings of the National Academy of Sciences of the United States of America 1994, 91:53-57.
82. Varela M., Ranuncolo S.M., Morand A., Lastiri J., De Kier Joffé E.B., Puricelli L.I., Pallotta M.G. EGF-R and PDGF-R, but not bcl-2, overexpression predict overall survival in patients with low-grade astrocytomas. Journal of Surgical Oncology 2004, 86:34-40.
83. Villoslada P., Hauser S.L., Bartke I., Unger J., Heald N., Rosenberg D., Cheung S.W., Mobley W.C., Fisher S., Genain C.P. Human nerve growth factor protects common marmosets against autoimmune encephalomyelitis by switching the balance of T helper cell type 1 and 2 cytokines within the central nervous system. Journal of Experimental Medicine 2000, 191:1799-1806.
84. Walters S.N., Morell P. Effects of altered thyroid states on myelinogenesis. Journal of Neurochemistry 1981, 36:1792-1801.
85. Whittemore S.R., Morassutti D.J., Walters W.M., Liu R.H., Magnuson D.S. Mitogen and substrate differentially affect the lineage restriction of adult rat subventricular zone neural precursor cell populations. Experimental Cell Research 1999, 252:75-95.
86. Williams A., Piaton G., Lubetzki C. Astrocytes - friends or foes in multiple sclerosis?. Glia 2007, 55:1300-1312.
87. Williams A., Piaton G., Aigrot M.S., Belhadi A., Theaudin M., Petermann F., Thomas J.L., Zalc B., Lubetzki C. Semaphorin 3A and 3F: key players in myelin repair in multiple sclerosis?. Brain 2007, 130:2554-2565.
88. Wolswijk G. Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells. Journal of Neuroscience 1998, 18:601-609.
89. Woodruff R.H., Fruttiger M., Richardson W.D., Franklin R.J. Platelet-derived growth factor regulates oligodendrocyte progenitor numbers in adult CNS and their response following CNS demyelination. Molecular and Cellular Neuroscience 2004, 25:252-262.
90. Zawadzka M., Rivers L.E., Fancy S.P., Zhao C., Tripathi R., Jamen F., Young K., Goncharevich A., Pohl H., Rizzi M., Rowitch D.H., Kessaris N., Suter U., Richardson W.D., Franklin R.J. CNS-resident glial progenitor/stem cells produce Schwann cells as well as oligodendrocytes during repair of CNS demyelination. Cell Stem Cell 2010, 6:578-590.
91. Zhang H., Jarjour A.A., Boyd A., Williams A. Central nervous system remyelination in culture - a tool for multiple sclerosis research. Experimental Neurology 2011, 230:138-148.
92. Zhou Y.X., Pannu R., Le T.Q., Armstrong R.C. Fibroblast growth factor 1 (FGFR1) modulation regulates repair capacity of oligodendrocyte progenitor cells following chronic demyelination. Neurobiology of Disease 2012, 45:196-205.